Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
International Journal of Medical SciencesPublished 1 January 2012Open access
Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Citations35
SJR quartileQ2
SJR score0.87
SNIP0.92
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The data strongly suggest the necessity of well-organized clinical studies with respect to antiplatelet-associated bleeding complications and suggest a stronger association for aspirin than clopidogrel.
Abstract
The data strongly suggest the necessity of well-organized clinical studies with respect to antiplatelet-associated bleeding complications.
Keywords
MedicinePharmacology, Toxicology and Pharmaceutics
New England Journal of MedicineMechanisms of Thrombus Formation
1,887 Citations2008Bruce Furie, Barbara C. Furie
This review is an account of recent advances in the understanding of the mechanisms of thrombus formation, with emphasis on two independent pathways: one involving primarily platelets and the other initiated by tissue factor.
Pharmacoepidemiology and Drug SafetyUse of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
1,730 Citations2001Stephen Evans, Patrick Waller +1 more
The process of generating ‘signals’ of possible unrecognized hazards from spontaneous adverse drug reaction reporting data has been likened to looking for a needle in a haystack but statistical approaches to the data have been underutilised.
European Journal of Clinical PharmacologyA Bayesian neural network method for adverse drug reaction signal generation
1,402 Citations1998Andrew Bate, Marie Lindquist +5 more
The BCPNN will be an extremely useful adjunct to the expert assessment of very large numbers of spontaneously reported ADRs, and can be used in the detection of significant signals from the data set of the WHO Programme on International Drug Monitoring.
Pharmacoepidemiology and Drug SafetyA comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
1,320 Citations2002Eugène van Puijenbroek, Andrew Bate +4 more
The objective of this study is to examine the level of concordance of the various estimates to the measure used by the WHO Collaborating Centre for International ADR monitoring, the information component (IC), when applied to the dataset of the Netherlands Pharmacovigilance Foundation Lareb.
NatureTriggers, targets and treatments for thrombosis
1,136 Citations2008Nigel Mackman
Thrombosis — localized clotting of the blood — can occur in the arterial or the venous circulation and has a major medical impact and is the most common cause of death in the developed world.
Pharmacoepidemiology and Drug SafetyQuantitative signal detection using spontaneous ADR reporting
858 Citations2009Andrew Bate, Stephen Evans
The role of Bayesian shrinkage in screening spontaneous reports, the importance of changes over time in screening the properties of the measures and some suggestions as to where emerging research is likely to lead are given.
Archives of Internal MedicineRisk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
839 Citations2010Morten Lock Hansen, Rikke Sørensen +12 more
In patients with AF, all combinations of warfarin, aspirin, and clopidogrel are associated with increased risk of nonfatal and fatal bleeding.
Drug SafetyUse of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database
688 Citations2002Ana Szarfman, Stella G. Machado +1 more
The operating characteristics of data mining in detecting early safety signals, exemplified by studying a drug recently well characterised by large clinical trials confirms the experience that the signals generated by data mining have high enough specificity to deserve further investigation.
Archives of Internal MedicineBleeding Complications With Warfarin Use
546 Citations2007Diane K. Wysowski, Parivash Nourjah +1 more
Annals of Internal MedicineWarfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
334 Citations2005Michael B. Rothberg, Carmel Celestin +3 more
A meta-analysis of randomized trials of warfarin therapy for individuals and the expected benefit for groups at varying risk for cardiovascular disease and bleeding found that patients at the highest risk for recurrent cardiovascular events should derive the most benefit, which may be offset in those with increased bleeding risk.
European Heart JournalAspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25 307 patients
290 Citations2005Felicita Andreotti, Luca Testa +2 more
For patients recovering from ACS, a combined strategy of A+W at INR values of 2-3 doubles the risk of MB, but is nonetheless superior to aspirin alone in preventing MAE.
Clinical Pharmacology & TherapeuticsNovel Statistical Tools for Monitoring the Safety of Marketed Drugs
252 Citations2007June S. Almenoff, Edward N. Pattishall +4 more
The statistical concepts behind these methods, as well as their practical application to monitoring the safety of pharmaceutical products using spontaneous AE reports are described and examples of how these tools can be used to identify novel drug interactions and demographic risk factors for adverse drug reactions are provided.
Archives of Internal MedicineCombined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
202 Citations2007Francesco Dentali
The findings question the current practice of using combined aspirin-OAC therapy except in patients with a mechanical heart valve, given the questionable benefits in reducing thromboembolic events and the increased risk of major bleeding.
Pharmacoepidemiology and Drug SafetyPractical pharmacovigilance analysis strategies
153 Citations2002A. Lawrence Gould
Two recently proposed Bayesian methods for quantitative pharmacovigilance can provide useful early signals of potential drug-event associations that subsequently can be the focus of detailed evaluation by skilled clinicians and epidemiologists.
Journal of Thrombosis and HaemostasisCombined antiplatelet and anticoagulant therapy: clinical benefits and risks
92 Citations2007John W. Eikelboom, J. Hirsh
Anticoagulation appears to be as effective as antiplatelet therapy for long‐term management of acute coronary syndrome and stroke, and possibly peripheral artery disease, but causes more bleeding, Therefore, in such patients who develop atrial fibrillation, switching from antiplatelets to anticoagulants might be all that is required.
Journal of Experimental & Clinical Cancer ResearchHypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
89 Citations2011Kaori Kadoyama, Akiko Kuwahara +4 more
The FDA's adverse event reporting system, AERS, and the data mining methods used herein are useful for confirming drug-associated adverse events, but the number of co-occurrences is an important factor in signal detection.
Archives of Internal MedicineComparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin
88 Citations2006James D. Douketis, Karin Arneklev +4 more
Treatment with ximelagatran, 36 mg twice daily, is associated with a lower risk of bleeding than warfarin in patients with nonvalvular atrial fibrillation.
CHEST JournalOutcomes Associated With Combined Antiplatelet and Anticoagulant Therapy
81 Citations2008Samuel G. Johnson, Kristina Rogers +2 more
The findings suggest that clinicians should carefully consider the risks and benefits when recommending combined antiplatelet therapy for patients receiving warfarin who do not meet the evidence-based criteria for such therapy.
Biological and Pharmaceutical BulletinAdverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting System
78 Citations2012Kaori Kadoyama, Toshiyuki Sakaeda +2 more
The adverse events suggested were in agreement with information provided by the manufacturer, suggesting that off-label use of tigecycline hardly results in unexpected adverse events, presumably due to usage with extreme caution.
PLoS ONEStatin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
70 Citations2011Toshiyuki Sakaeda, Kaori Kadoyama +1 more
Signals were detected for 4 statins with respect to myalgia, rhabdomyolysis, and an increase in creatine phosphokinase level, but these signals were stronger for rosuvastatin than pravastatin and atorvastsatin, and the association was marginal.
International Journal of Medical SciencesAdverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
68 Citations2012Kaori Kadoyama, Ikuya Miki +4 more
The results obtained herein were consistent with clinical observations, suggesting the usefulness of the FDA's AERS database and data mining methods used, but the number of co-occurrences is an important factor in signal detection.
International Journal of Medical SciencesAdverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
66 Citations2011Toshiyuki Sakaeda, Kaori Kadoyama +1 more
The results obtained were consistent with clinical observations, suggesting the usefulness of the FDA's adverse event reporting system, AERS, and the data mining method used herein.
Blood ReviewsEffectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials
46 Citations2011Jeremy S. Paikin, Doug S. Wright +1 more
International Journal of Medical SciencesPlatinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
42 Citations2011Toshiyuki Sakaeda, Kaori Kadoyama +5 more
The FDA's adverse event reporting system, AERS, with optimized data mining tools is useful to authorize potential associations between platinum agents and hypersensitivity reactions.
Journal of General Internal MedicineShould aspirin be continued in patients started on warfarin?
42 Citations2004Robin J. Larson, Elliott S. Fisher
For mechanical heart valve patients, the benefits of continuing aspirin when starting warfarin therapy are clear and there are not adequate data to guide this common clinical decision.
International Journal of Medical SciencesOmeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
39 Citations2012Takao Tamura, Toshiyuki Sakaeda +2 more
The data obtained in this study do not provide sufficient evidence to recommend systematic monitoring of magnesium levels in plasma, but chronic exposure to a PPI can lead to severe hypomagnesaemia.
Thrombosis ResearchCombination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?
22 Citations2011James D. Douketis
Which patients are receiving combined warfarin-aspirin therapy is described, the evidence for the therapeutic benefit and harm is summarized, and practical guidelines as to which patients should, and should not, receive such treatment are suggested.